Back to Search
Start Over
Lower concentrations of clarithromycin suppress urease activity, motility, and binding to gastric epithelial cells in Helicobacter pylori isolates.
- Source :
-
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [Dig Liver Dis] 2002 Jul; Vol. 34 (7), pp. 489-97. - Publication Year :
- 2002
-
Abstract
- Background: Our previous study showed that histological scores of gastric mucosal inflammation and Helicobacter pylori density decreased even in patients who failed to eradicate Helicobacter pylori after antimicrobial therapy including clarithromycin. This may reflect indirect suppressive effects of lower concentrations of clarithromycin on Helicobacter pylori, as suggested in other Gram-negative rod infections.<br />Aims: To investigate whether clarithromycin suppresses virulence factors of Helicobacter pylori at sub-minimal inhibitory concentration.<br />Methods: Six clarithromycin-susceptible Helicobacter pylori isolates and 7 clarithromycin-resistant isolates were obtained from patients with peptic ulcer disease. These isolates were analysed for urease activity, motility, and ability to bind to gastric epithelial cells after they were incubated with or without clarithromycin at sub-minimal inhibitory concentrations.<br />Results: Incubation of Helicobacter pylori isolates with clarithromycin at sub-minimal inhibitory concentrations reduced urease activity motility, and binding to gastric epithelial cells in a dose-dependent manner. These findings were observed both in clarithromycin-susceptible and resistant strains.<br />Conclusions: Suppressive effects of clerithromycin on virulence factors of Helicobacter pylori at sub-minimal inhibitory concentrations may be associated with observed attenuation of gastric inflammation and Helicobacter pylori density in patients who failed in bacterial eradication after triple therapy including clarithromycin.
- Subjects :
- Binding, Competitive drug effects
Disease Susceptibility
Dose-Response Relationship, Drug
Drug Resistance, Microbial genetics
Epithelial Cells drug effects
Gastric Mucosa metabolism
Helicobacter Infections drug therapy
Helicobacter Infections enzymology
Helicobacter Infections microbiology
Helicobacter pylori enzymology
Helicobacter pylori isolation & purification
Humans
Peptic Ulcer drug therapy
Peptic Ulcer enzymology
Peptic Ulcer microbiology
Treatment Outcome
Urease drug effects
Anti-Bacterial Agents pharmacology
Anti-Bacterial Agents therapeutic use
Clarithromycin pharmacology
Clarithromycin therapeutic use
Epithelial Cells metabolism
Gastrointestinal Motility drug effects
Helicobacter pylori drug effects
Stomach cytology
Urease metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1590-8658
- Volume :
- 34
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
- Publication Type :
- Academic Journal
- Accession number :
- 12236482
- Full Text :
- https://doi.org/10.1016/s1590-8658(02)80107-4